LTRN Stock Summary and Trading Ideas (Lantern Pharma | NASDAQ:LTRN)

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Lantern Pharma trades on the NASDAQ stock market under the symbol LTRN.

As of March 6, 2026, LTRN stock price declined to $2.70 with 16,497 million shares trading.

LTRN has a beta of 1.00, meaning it tends to be more sensitive to market movements. LTRN has a correlation of 0.07 to the broad based SPY ETF.

LTRN has a market cap of $30.20 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, LTRN traded as high as $11.99 and as low as $2.38.

The top ETF exchange traded funds that LTRN belongs to (by Net Assets): VTI, VXF, MEDX, IWC, DFSU.

LTRN has underperformed the market in the last year with a return of -30.6%, while the SPY ETF gained +18.7%. In the last 3 month period, LTRN fell short of the market, returning -28.0%, while SPY returned -1.7%. However, in the most recent 2 weeks LTRN has outperformed the stock market by returning +3.4%, while SPY returned -2.5%.

LTRN support price is $2.56 and resistance is $2.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LTRN shares will trade within this expected range on the day.